Resultados da busca - Kesavadev, Jothydev
- Mostrando 1 - 20 resultados de 33
- Ir para a próxima página
-
1
-
2
-
3
-
4
Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus por Kalra, Sanjay, Kesavadev, Jothydev, Chadha, Manoj, Kumar, G. Vijaya
Publicado em 2018Texto -
5
-
6
-
7
-
8
Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM) por Kesavadev, Jothydev, Pillai, Pradeep Babu Sadasivan, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
Publicado em 2017Texto -
9
-
10
-
11
Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization por Kesavadev, Jothydev, Misra, Anoop, Saboo, Banshi, Aravind, S.R., Hussain, Akhtar, Czupryniak, Leszek, Raz, Itamar
Publicado em 2021Texto -
12
Exploratory CSII Randomized Controlled Trial on Erectile Dysfunction in T2DM Patients (ECSIITED) por Kesavadev, Jothydev, Sadasivan Pillai, Pradeep Babu, Shankar, Arun, Warrier, Rohit S., Ramachandran, Lakshmy, Jothydev, Sunitha, Krishnan, Gopika
Publicado em 2018Texto -
13
Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market por Murthy, Sreenivasa, Aneja, Pankaj, Asirvatham, Arthur Joseph, Husemoen, Lise Lotte N., Rhee, Nicolai A., Kesavadev, Jothydev
Publicado em 2021Texto -
14
Use of Insulin Pumps in India: Suggested Guidelines Based on Experience and Cultural Differences por Kesavadev, Jothydev, Das, Ashok Kumar, Unnikrishnan, Ranjit, Joshi, Shashank R., Ramachandran, Ambady, Shamsudeen, Jisha, Krishnan, Gopika, Jothydev, Sunitha, Mohan, Viswanathan
Publicado em 2010Texto -
15
Our First 825 T2DM Patients on 14-Day Factory-Calibrated Glucose Monitoring System: Clinical Utility and Challenges por Kesavadev, Jothydev, Shankar, Arun, Ashok, Ashwin David, Srinivas, Sheeja, Ajai, Neethu Annie, Sanal, Geethu, Krishnan, Gopika, Ramachandran, Lakshmy, Jothydev, Sunitha
Publicado em 2017Texto -
16
Challenges in Type 1 diabetes management in South East Asia: Descriptive situational assessment por Kesavadev, Jothydev, Sadikot, Shaukat M., Saboo, Banshi, Shrestha, Dina, Jawad, Fatema, Azad, Kishwar, Wijesuriya, Mahendra Arunashanthi, Latt, Tint Swe, Kalra, Sanjay
Publicado em 2014Texto -
17
Unproven Therapies for Diabetes and Their Implications por Kesavadev, Jothydev, Saboo, Banshi, Sadikot, Shaukat, Das, Ashok Kumar, Joshi, Shashank, Chawla, Rajeev, Thacker, Hemant, Shankar, Arun, Ramachandran, Lakshmy, Kalra, Sanjay
Publicado em 2016Texto -
18
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting por Chadha, Manoj, Das, Ashok Kumar, Deb, Prasun, Gangopadhyay, Kalyan Kumar, Joshi, Shashank, Kesavadev, Jothydev, Kovil, Rajiv, Kumar, Surender, Misra, Anoop, Mohan, Viswanathan
Publicado em 2022Texto -
19
Suggested use of vaccines in diabetes por Kesavadev, Jothydev, Misra, Anoop, Das, Ashok Kumar, Saboo, Banshi, Basu, Debasis, Thomas, Nihal, Joshi, Shashank R., Unnikrishnan, A. G., Shankar, Arun, Krishnan, Gopika, Unnikrishnan, Ranjit, Mohan, Viswanathan
Publicado em 2012Texto -
20
One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study) por Kesavadev, Jothydev, Murthy, L.Sreenivasa, Chaudhury, Tirthankar, Yalamanchi, Sadasiva Rao, Giri, J., Gupta, Sunil, Phatak, Sanjeev, Modi, K.D., Chatterjee, Sanjay, Manjunath, Aparna, Revanna, Manjunatha, Bhattacharya, Arpandev
Publicado em 2022Texto